McIlwain Matthew S 13D/13G Filings for Nautilus Biotechnology, Inc. (NAUT)

McIlwain Matthew S 13D and 13G filings for Nautilus Biotechnology, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2021-08-25
8:58 pm
Purchase
2021-06-0913DNautilus Biotechnology, Inc.
NAUT
McIlwain Matthew S6,368,136
5.130%
6,368,136increase
(New Position)
Filing